8q22.1 microdeletion syndrome

8q22.1 microdeletion syndrome (Orphanet code 178303) is a rare chromosomal disorder caused by a submicroscopic deletion on the long arm of chromosome 8 at band q22.1. This contiguous gene deletion syndrome affects multiple body systems and is characterized by a recognizable pattern of clinical features including intellectual disability, developmental delay, growth retardation, and distinctive craniofacial dysmorphisms. Facial features may include a broad forehead, hypertelorism, a depressed nasal bridge, and ear anomalies. Affected individuals may also present with skeletal abnormalities, cardiac defects, and genitourinary anomalies. The syndrome is typically identified through chromosomal microarray analysis (array CGH), which can detect the submicroscopic deletion that is not visible on standard karyotyping. The severity of clinical manifestations can vary depending on the size of the deletion and the specific genes involved. Most cases are de novo, meaning the deletion occurs as a new event and is not inherited from a parent, though parental chromosomal studies are recommended to assess recurrence risk. There is currently no cure or targeted therapy for 8q22.1 microdeletion syndrome. Management is supportive and symptom-based, involving a multidisciplinary team that may include developmental pediatricians, cardiologists, orthopedic specialists, and speech and occupational therapists. Early intervention programs for developmental delay and intellectual disability are important components of care. Regular monitoring for associated complications, including cardiac and renal anomalies, is recommended.

Common questions about 8q22.1 microdeletion syndrome